Adding agents such as SGLT2 inhibitors can provide complementary benefits by improving glucose control while promoting additional weight loss and cardiovascular protection
Melzer J, Iten F, Reichling J, Saller R
Monitor cognition and brain health : If using GLP-1 agents, baseline cognitive testing (memory, executive function) and periodic follow-up may help document whether there is slowing of decline (though in routine practice, this is limited)
Experimental study demonstrates that LDN induces a phenotypic shift in BV-2 microglial cells, transitioning them from a pro-inflammatory(iNOS high CD206 low ) to a quiescent, anti-inflammatory M2 state (iNOS low CD206 high ) [150]
Thank you Mandie NAT T This was the first time Ive been to Mandie and I felt very comfortable throughout, and had a great experience
Li and Seto, 2016